DK1074558T3 - Proces til fremstilling af mometasonefuroat - Google Patents

Proces til fremstilling af mometasonefuroat

Info

Publication number
DK1074558T3
DK1074558T3 DK99308380T DK99308380T DK1074558T3 DK 1074558 T3 DK1074558 T3 DK 1074558T3 DK 99308380 T DK99308380 T DK 99308380T DK 99308380 T DK99308380 T DK 99308380T DK 1074558 T3 DK1074558 T3 DK 1074558T3
Authority
DK
Denmark
Prior art keywords
mometasone
nephropate
manufacturing
furoate
free
Prior art date
Application number
DK99308380T
Other languages
Danish (da)
English (en)
Inventor
William Dr Heggie
Joao Bandarra
Original Assignee
Hovione Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovione Int Ltd filed Critical Hovione Int Ltd
Application granted granted Critical
Publication of DK1074558T3 publication Critical patent/DK1074558T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99308380T 1999-08-02 1999-10-25 Proces til fremstilling af mometasonefuroat DK1074558T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT102343A PT102343B (pt) 1999-08-02 1999-08-02 Processo para a preparacao de furoato mometasona

Publications (1)

Publication Number Publication Date
DK1074558T3 true DK1074558T3 (da) 2003-04-07

Family

ID=20085881

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99308380T DK1074558T3 (da) 1999-08-02 1999-10-25 Proces til fremstilling af mometasonefuroat

Country Status (22)

Country Link
US (1) US6177560B1 (ja)
EP (1) EP1074558B1 (ja)
JP (1) JP3746174B2 (ja)
KR (1) KR100640066B1 (ja)
CN (1) CN1149222C (ja)
AT (1) ATE229970T1 (ja)
AU (1) AU765592B2 (ja)
CA (1) CA2295455C (ja)
DE (1) DE69904585T2 (ja)
DK (1) DK1074558T3 (ja)
ES (1) ES2189354T3 (ja)
HR (1) HRP990341B1 (ja)
HU (1) HU227494B1 (ja)
IL (1) IL133752A (ja)
NO (1) NO321154B1 (ja)
NZ (1) NZ500555A (ja)
PL (1) PL191103B1 (ja)
PT (1) PT102343B (ja)
RU (1) RU2208616C2 (ja)
SI (1) SI1074558T1 (ja)
UA (1) UA60333C2 (ja)
ZA (1) ZA996758B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
EP1790754A1 (de) * 2005-11-24 2007-05-30 Siemens Aktiengesellschaft Schichtsystem mit Gadolinium-Mischkristall-Pyrochlorphase
US8021742B2 (en) * 2006-12-15 2011-09-20 Siemens Energy, Inc. Impact resistant thermal barrier coating system
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
RU2580315C3 (ru) 2009-05-29 2021-06-18 Перл Терапьютикс, Инк. Композиции для респираторной доставки активных веществ и связанные с ними способы и системы
PT105139B (pt) * 2010-06-01 2013-01-29 Hovione Farmaciencia S A Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos
SG11201507286QA (en) 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
EP2999460A1 (en) 2013-05-22 2016-03-30 Pearl Therapeutics, Inc. Compositions, methods&systems for respiratory delivery of three or more active agents
CN105481933B (zh) * 2015-12-25 2017-09-19 山东京卫制药有限公司 一种合成糠酸莫米松的方法
CN105566437B (zh) * 2015-12-30 2018-07-20 山东京卫制药有限公司 一种8dm衍生物及利用其合成糠酸莫米松的方法
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法
MX2024000468A (es) 2021-07-09 2024-04-05 Astrazeneca Pharmaceuticals Lp Composiciones, metodos y sistemas para la administracion de farmacos en aerosol.
CN118414148A (zh) 2021-12-20 2024-07-30 阿斯利康(瑞典)有限公司 用于气溶胶药物递送的组合物、方法和系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
CZ293944B6 (cs) * 1996-06-28 2004-08-18 Scheringácorporation Způsob přípravy �@esterů @alfaŹ@�@dihalogenpregnan@��betaŹ�@alfa@diol@onů
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones

Also Published As

Publication number Publication date
NZ500555A (en) 2000-11-24
HUP9903747A3 (en) 2001-07-30
DE69904585D1 (de) 2003-01-30
HU227494B1 (en) 2011-07-28
KR100640066B1 (ko) 2006-10-31
ES2189354T3 (es) 2003-07-01
SI1074558T1 (en) 2003-04-30
PT102343A (pt) 2001-02-28
US6177560B1 (en) 2001-01-23
KR20010020094A (ko) 2001-03-15
NO321154B1 (no) 2006-03-27
AU765592B2 (en) 2003-09-25
HRP990341A2 (en) 2001-04-30
NO995225D0 (no) 1999-10-26
PT102343B (pt) 2003-11-28
HRP990341B1 (en) 2003-10-31
ZA996758B (en) 2000-08-30
CA2295455C (en) 2008-03-25
CN1282744A (zh) 2001-02-07
JP3746174B2 (ja) 2006-02-15
NO995225L (no) 2001-02-05
CN1149222C (zh) 2004-05-12
UA60333C2 (uk) 2003-10-15
RU2208616C2 (ru) 2003-07-20
HUP9903747A2 (hu) 2001-05-28
HU9903747D0 (en) 1999-12-28
IL133752A0 (en) 2001-04-30
EP1074558A1 (en) 2001-02-07
EP1074558B1 (en) 2002-12-18
JP2001048897A (ja) 2001-02-20
DE69904585T2 (de) 2003-05-15
IL133752A (en) 2004-02-19
AU5602499A (en) 2001-02-08
CA2295455A1 (en) 2001-02-02
PL336452A1 (en) 2001-02-12
PL191103B1 (pl) 2006-03-31
ATE229970T1 (de) 2003-01-15

Similar Documents

Publication Publication Date Title
DK1074558T3 (da) Proces til fremstilling af mometasonefuroat
DE69529778D1 (de) Präzisionsbrenner zum Oxidieren von halogenidfreien, Silizium enthaltenden Verbindungen
FI902415A0 (fi) Oxadiazolderivat och dess salter, anvaendning av dessa vid behandling av demens, framstaellning och formulationer.
FI911183A (fi) Syrastabiliserat kalciumkarbonat, foerfarande foer dess framstaellning och foerfarande foer dess anvaendning vid framstaellning av surt papper.
DK1870417T3 (da) Peptidacceptor-ligeringsmetoder
FI935440A (fi) Tarttuvuutta modifioiva silikoonijärjestelmä ja sen käyttö kovettuvien ei-tarttuvien koostumusten valmistamiseksi
DK0802942T3 (da) Biologisk nedbrydlige polymerer, fremgangsmåder til deres fremstilling, samt deres anvendelse til fremstilling af bionedbry
AU6675400A (en) Software code protection by obscuring its data-driven form
DE69402871D1 (de) Photo-härtbare überzugszusammensetzungen
NO20020197L (no) Renseapparat og fremgangsmåte som utnytter en siloksanblanding som et lösemiddel
DK12893A (da) Fremgangsmåde til fremstilling af normal såvel som ultrafin cement
DK0696937T3 (da) Fremgangsmåde til behandling af spontant forbrændelige katalysatorer
WO2001042853A3 (en) Photoresist composition for deep uv radiation
PT991416E (pt) Plasma sanguineo universalmente aplicavel
BR9205854A (pt) Composiçoes de mistura curavel por UV e processos.
DE50114006D1 (de) Transdermalsystem enthaltend ein hochpotentes gestagen
DE69607569D1 (de) Fotoempfindliche paste und plasmaanzeigetafel, sowie verfahren zu deren herstellung
DE3783216D1 (de) Verfahren zum schutz von pflanzen gegen krankheiten.
NO20052329L (no) Fremgangsmate for rensingen av 1,4-butandiol-mononitrat
DK0703907T3 (da) Fremgangsmåde til fremstilling af terapeutisk aktive taxoider
DK1029867T3 (da) Fremgangsmåde til fremstilling af organiske azider
DK0923565T3 (da) Fremgangsmåde til fremstilling af paclitaxel
FI915244A0 (fi) Biometallurgisk process i vilken biooxidation av mineralfoereningar utfoeres.
BR9609310A (pt) Derivados de 1,3-OXA(TIA)ZINA
WO2003044877A3 (en) Light emitting device and compounds for use therein